The antiproliferative effect of the somatostatin analog octreotide was suggested to be associated with the upregulation of ZAC1 expression [15], which was shown to correlate with the IGF-I response and tumor shrinkage [27]. This evidence concerns the gene IGF1 and neoplasm.